|
|
| Line 1,252: |
Line 1,252: |
| | || | | | || |
| |- | | |- |
| |T-prolymphocytic leukaemia||Disease|| || || || || ||SK|| | | |T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||HD|| |
| | || | | | || |
| | |- |
| | |Early T-precursor lymphoblastic leukaemia / lymphoma |
| | |Disease |
| | |Fei Yang, MD, FACMG, Kaiser Permanente Northwest |
| | | |
| | | |
| | | |
| | | |
| | |HD |
| | | |
| | | |
| | | |
| | |- |
| | |T-prolymphocytic leukaemia |
| | |Disease |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |SK |
| | | |
| | | |
| | | |
| |- | | |- |
| |T-large granular lymphocytic leukaemia||Disease||*Michelle Don, MD, MS|| || || || ||SK|| | | |T-large granular lymphocytic leukaemia||Disease||*Michelle Don, MD, MS|| || || || ||SK|| |
| Line 1,477: |
Line 1,501: |
| | | | | |
| | | | | |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| | || || || || || || || ||
| |
| | ||
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma||Disease|| || || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy||Disease||Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with hypodiploidy||Disease||Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with iAMP21||Disease||Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion||Disease||Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features||Disease||Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement||Disease||Yassmine Akkari Nicolas Millan|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion||Disease||Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features||Disease|| || || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion||Disease||Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion||Disease||Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO|| || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion||Disease|| || || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations||Disease|| || || || || ||YA||
| |
| | ||
| |
| |-
| |
| |B-lymphoblastic leukaemia/lymphoma, NOS||Disease|| || || || || ||YA||
| |
| | ||
| |
| |-
| |
| |T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||YA||
| |
| | ||
| |
| |-
| |
| |Early T-precursor lymphoblastic leukaemia / lymphoma||Disease||Fei Yang, MD, FACMG, Kaiser Permanente Northwest|| || || || ||YA||
| |
| | ||
| |
| |- | | |- |
| |Fanconi anaemia||Disease|| || || || || ||NA|| | | |Fanconi anaemia||Disease|| || || || || ||NA|| |
